Similarly, in conditions in which SAA levels are chronically elevated, such as diabetes (54), rheumatoid arthritis (9, 25), and chronic renal dysfunction (55, 56); susceptibility to SAA-mediated endothelial damage may promote CVD and related vascular complications. This evidence concerns the gene SAA1 and rheumatoid arthritis.